By the late 1980's, companies like Nextran and Imutran were trying to figure out how to use transgenic technology for commercial gain.

Brigid L. M. Hogan FRS is a British developmental biologist noted for her contributions to stem cell research and transgenic technology and techniques.

This transgenic technology is now being applied in the search for a treatment for the genetic disorder Huntington's disease.

A resistance management plan is intended to sustain the useful life of transgenic technology and well as the utility of the toxin for organic farmers.

It said, however, that "transgenic technology promises more and better crops and food animals to feed a continuously growing world population."

The difference between knock-in technology and transgenic technology is that a knock-in involves a gene inserted into a specific locus, and is a "targeted" insertion.

Still, it is clear that advances in transgenic technology have fueled a wave of corporate deal making, including marketing and research alliances, cross-investments and acquisitions.

In the past year the CGR has developed a number of new applications of transgenic and genome technology which focus on a small number of areas of interest.

There will be research laboratories of various disciplines e.g. Genomics, Nutrition enrichment, transgenic technology, infectious diseases and Reproductive biotechnology.

In the cloning of human beings, whether by segmentation of the egg or by transgenic technology, as was the case with Dolly the ewe, an absolute prohibition must be maintained.